Aging is among the top known risk factors for most human diseases. Understanding the
biology of aging holds the promise to prevent or treat a wide range of seemingly
unrelated diseases. Originally being viewed as a passive and irreversible accumulation
of changes over time, aging is currently perceived as a progressive biological decline
that succumbs to genetic manipulations. Hallmarks of aging have been identified,
including but not limited to, stem cell exhaustion, mitochondrial dysfunction, deregulated
nutrient sensing, and genomic instability. However, the molecular mechanisms
determining the aging process remain elusive. In particular, the cell/tissue specific
responses to aging-associated damages still await investigation. This knowledge is
pivotal to understand the molecular basis of the heterogeneous effects of aging on
diverse tissues. The aim of this dissertation work was to gain molecular insights into this
knowledge by studying the two striking aspects of aging: stem cell dysfunction and
chronic inflammation.
Adult stem cells maintain tissue homeostasis throughout life. It has been known for
decades that adult stem cell function declines with age, however, the exact mechanisms
contributing to this degeneration remain tentative. We found that SIRT2, a primarily
cytosolic NAD+-dependent deacetylase, is required for hematopoietic stem cell (HSC)
maintenance at old age. Mechanistic studies demonstrated that SIRT2 exerts its role
through modulating cell death processes in HSCs. SIRT2 expression is significantly
reduced in old HSCs, which is consistent with increased cell death in HSCs during
aging. Enforced SIRT2 expression reverses the increased cell death observed in HSCs
during physiological aging. Further, we show that restoring SIRT2 expression can
rejuvenate the functionality of old HSCs, suggesting the reversibility of the functional
decline in HSCs with age.
SIRT2 has been reported to suppress inflammation in multiple inflammation-inducing
mouse models. Based on these findings, we investigated SIRT2’s role in chronic sterile
inflammation associated with physiological aging. Chronic NLRP3 inflammasome
activation during aging has a causal role in developing pathological inflammation in
sterile inflammatory diseases, such as atherosclerosis, Alzheimer’s disease,
Parkinson’s disease, obesity, diabetes, multiple sclerosis, and cancer. In light of this, we
explored whether SIRT2 suppresses aging-associated chronic inflammation through
regulating the NLRP3 inflammasome activity. We found that SIRT2 specifically inhibits
NLRP3 inflammasome in macrophages. NLRP3 inflammasome is activated in
macrophages with age, with a concomitant reduction in SIRT2 levels. Enforced SIRT2
expression in macrophages from old mice reverses aging-associated NLRP3
inflammasome activation, suggesting a potential reversible mechanism for the agingassociated
inflammation phenotype.
Our studies demonstrate that down-regulation of SIRT2 levels plays significant roles in
different cells and tissues during aging. In HSCs, SIRT2 suppresses the activation of
cell death processes and preserves HSC regenerative capacity, while in macrophages,
SIRT2 mediated NLRP3 inhibition prevents the development of chronic inflammation.
These results not only broaden the physiological relevance of the cytosolic NAD+
protein deacetylase SIRT2 to include stem cell homeostasis, but also exemplify the
heterogeneity in tissue responses to aging-associated down-regulation of the SIRT2
protein expression. Further, from the therapeutic standpoints, these findings also open
novel avenues to explore the potential reversibility of both stem cell aging and systemic
low-grade inflammation associated with aging.